These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

808 related items for PubMed ID: 10784066

  • 1. Increased survival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor.
    Espejo M, Cutillas B, Arenas TE, Ambrosio S.
    Cell Transplant; 2000; 9(1):45-53. PubMed ID: 10784066
    [Abstract] [Full Text] [Related]

  • 2. Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum.
    Granholm AC, Mott JL, Bowenkamp K, Eken S, Henry S, Hoffer BJ, Lapchak PA, Palmer MR, van Horne C, Gerhardt GA.
    Exp Brain Res; 1997 Aug; 116(1):29-38. PubMed ID: 9305812
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo.
    Strömberg I, Björklund L, Johansson M, Tomac A, Collins F, Olson L, Hoffer B, Humpel C.
    Exp Neurol; 1993 Dec; 124(2):401-12. PubMed ID: 7904571
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Implantation of bioactive growth factor-secreting rods enhances fetal dopaminergic graft survival, outgrowth density, and functional recovery in a rat model of Parkinson's disease.
    Törnqvist N, Björklund L, Almqvist P, Wahlberg L, Strömberg I.
    Exp Neurol; 2000 Jul; 164(1):130-8. PubMed ID: 10877923
    [Abstract] [Full Text] [Related]

  • 10. Effects of glial cell line-derived neurotrophic factor on developing and mature ventral mesencephalic grafts in oculo.
    Johansson M, Friedemann M, Hoffer B, Strömberg I.
    Exp Neurol; 1995 Jul; 134(1):25-34. PubMed ID: 7672036
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Glial cell line-derived neurotrophic factor-supplemented hibernation of fetal ventral mesencephalic neurons for transplantation in Parkinson disease: long-term storage.
    Hebb AO, Hebb K, Ramachandran AC, Mendez I.
    J Neurosurg; 2003 May; 98(5):1078-83. PubMed ID: 12744369
    [Abstract] [Full Text] [Related]

  • 15. Minor immunoreactivity in GDNF-, BDNF-, or NT-3-treated substantia nigra allografts.
    Shinoda M, Hoffer BJ, Olson L.
    J Neural Transplant Plast; 1997 May; 6(2):83-96. PubMed ID: 9306240
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Simultaneous Transplantation of Fetal Ventral Mesencephalic Tissue and Encapsulated Genetically Modified Cells Releasing GDNF in a Hemi-Parkinsonian Rat Model of Parkinson's Disease.
    Perez-Bouza A, Di Santo S, Seiler S, Meyer M, Andereggen L, Huber A, Guzman R, Widmer HR.
    Cell Transplant; 2017 Sep; 26(9):1572-1581. PubMed ID: 29113462
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease.
    Andereggen L, Meyer M, Guzman R, Ducray AD, Widmer HR.
    Brain Res; 2009 Jun 18; 1276():39-49. PubMed ID: 19389387
    [Abstract] [Full Text] [Related]

  • 20. Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease.
    Höglinger GU, Widmer HR, Spenger C, Meyer M, Seiler RW, Oertel WH, Sautter J.
    Exp Neurol; 2001 Jan 18; 167(1):148-57. PubMed ID: 11161602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.